Cargando…
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
Although current anticancer immunotherapies using immune checkpoint inhibitors (ICIs) have been reported with a high clinical success rate, numerous patients still bear ‘cold’ tumors with insufficient T cell infiltration and low immunogenicity, responding poorly to ICI therapy. Considering the advan...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Nature Singapore
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006526/ https://www.ncbi.nlm.nih.gov/pubmed/34138315 http://dx.doi.org/10.1007/s40820-021-00622-6 |